February 25, 2022 Comments Off on Pharmaceutical companies with the most ‘New Combination’ drugs Posted in: Infographic This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations are one of the categories for which the FDA grants…
The post Pharmaceutical companies with the most ‘New Combination’ dru…
February 24, 2022 Comments Off on New patent for Biofrontera drug AMELUZ Posted in: Patent Added Annual Drug Patent Expirations for AMELUZ Ameluz is a drug marketed by Biofrontera and is included in one NDA. It is available from one supplier. The generic ingredient in AMELUZ…
The post New patent for Biofrontera drug AMELUZ appeared first on DrugPa…
